Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Dermal filler industry 360º synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product type trends
2.1.4 Material type trends
2.1.5 Application trends
2.1.6 End-use trends
Chapter 3 Dermal Filler Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Growing elderly population globally
3.3.1.2 Rising focus and awareness about facial aesthetics in developed regions
3.3.1.3 Surge in demand for minimally invasive cosmetic procedures
3.3.1.4 Growing number of facilities and professionals in developed countries
3.3.2 Industry pitfalls & challenges
3.3.2.1 Increasing number of complications post procedures
3.3.2.2 Lack of regulatory guidelines
3.4 Growth potential analysis
3.4.1 By product type
3.4.2 By material type
3.4.3 By application
3.4.4 By end-use
3.5 COVID- 19 impact analysis
3.6 Future market trends
3.7 Technology landscape
3.8 Gap analysis
3.9 Clinical trials data
3.9.1 Allegan plc (AbbVie)
3.9.2 Galderma SA
3.9.3 Merz Pharma GmbH & Co. KGaA
3.10 Regulatory landscape
3.10.1 U.S.
3.10.2 Europe
3.11 Porter's analysis
3.12 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 AbbVie (Allergan plc)
4.1.2 Sinclair Pharma Limited (Huadong Medicine Co., Ltd)
4.1.3 Galderma S.A.
4.2 Company matrix analysis, 2022
4.3 Company market share analysis, 2022
4.4 Strategy dashboard, 2022
Chapter 5 Dermal Filler Market Size and Forecast, By Product Type (USD Million)
5.1 Key trends, by product type
5.2 Absorbable
5.3 Non-absorbable
Chapter 6 Dermal Filler Market Size and Forecast, By Material Type (USD Million)
6.1 Key trends, by material type
6.2 Hyaluronic acid (HA)
6.2.1 Face lift
6.2.2 Facial corrections
6.2.3 Wrinkles reduction
6.2.4 Breast enhancement
6.2.5 Acne scar treatment
6.2.6 Lip enhancement
6.2.7 Other applications
6.3 Calcium hydroxylapatite
6.3.1 Facial corrections
6.3.2 Wrinkles reduction
6.3.3 Acne scar treatment
6.3.4 Other applications
6.4 Poly-L-lactic acid
6.4.1 Facial corrections
6.4.2 Wrinkles reduction
6.4.3 Breast enhancement
6.4.4 Acne scar treatment
6.4.5 Other applications
6.5 Polymethyl-methacrylate microspheres (PMMA)
6.5.1 Facial corrections
6.5.2 Wrinkles reduction
6.5.3 Acne scar treatment
6.6 Collagen
6.6.1 Face lift
6.6.2 Facial corrections
6.6.3 Wrinkles reduction
6.6.4 Breast enhancement
6.6.5 Acne scar treatment
6.6.6 Other applications
6.7 Fat fillers
6.7.1 Face lift
6.7.2 Facial corrections
6.7.3 Wrinkles reduction
6.7.4 Breast enhancement
6.7.5 Acne scar treatment
6.7.6 Other applications
6.8 Other material types
6.8.1 Wrinkles reduction
6.8.2 Hand rejuvenation
6.8.3 Acne scar
Chapter 7 Dermal Filler Market Size and Forecast, By Application (USD Million)
7.1 Key trends, by application
7.2 Face lift
7.3 Facial corrections
7.4 Wrinkles reduction
7.5 Acne scar
7.6 Lipoatrophy
7.7 Lip enhancement
7.8 Hip augmentation
7.9 Breast enhancement
7.10 Hand rejuvenation
7.11 Penis enlargement
7.12 Blepharoplasty
7.13 Neck & chin lift
7.14 Other applications
Chapter 8 Dermal Filler Market Size and Forecast, By End-use (USD Million)
8.1 Key trends, by end-use
8.2 Hospitals
8.3 Dermatology clinics
8.4 Other end-users
Chapter 9 Dermal Filler Market Size and Forecast, By Region (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 MEA
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of MEA
Chapter 10 Company Profiles
10.1 AbbVie Inc (Allergan Plc.)
10.2 Sinclair Pharma (Huadong Medicine Co., Ltd)
10.3 Galderma S.A.
10.4 Merz Pharma GmbH & Co. KGaA.
10.5 Mesoestetic
10.6 Suneva Medical, Inc
10.7 Teoxane Laboratories
10.8 Cytophil, Inc.
10.9 Dr. Korman Laboratories Ltd.
10.10 Vital Esthetique
10.11 Bioxis Pharmaceuticals
10.12 Laboratories Vivacy SAS
